TRHC’s new pharmacotherapy R&D institute to be based in Orlando
Category: #research  By Akshay Kedari  Date: 2019-02-23
  • share
  • Twitter
  • Facebook
  • LinkedIn

TRHC’s new pharmacotherapy R&D institute to be based in Orlando

The newly established research institute will look forward to forging partnerships with significant pharmaceutical and academic entities in the region.

Tabula Rasa HealthCare, Inc., the renowned healthcare technology firm, has made it to the headlines for having declared the launch of its new Scientific Precision Pharmacotherapy Research and Development Institute. Reportedly, the Institute will be based out of Orlando, within Lake Nona Medical City.

According to sources familiar with the knowledge of the matter, TRHC's Research & Development Institute is strongly dedicated to developing proprietary products. These products apparently, will be aimed toward the optimization of medication regimes in order to reduce medical care expenditure, enhance patient outcomes, lower the healthcare service utilization, and manage risk. The Institute will also ensure the validation and recognition of these products from the scientific and regulatory communities.

Reportedly, the research vision of the TRHC Institute expands with the new research initiatives cropping up, inclusive of biomedical engineering systems, translational research, patient-specific information, nanoscale science, data-driven technologies and solutions, and bioinformatics.

According to an official press release by Tabula Rasa HealthCare, Calvin H. Knowlton, the CEO & Chairman of the company, stated that the new research institute intends to focus on enhancing the firm’s decision support tools via extensive research, deploying computer simulations, computational modeling, and pharmacokinetics & pharmacodynamics modeling. The basic objective here is to optimize and manufacture novel products in association with the company’s Medication Risk StratificationTM and Medication Risk MitigationTM technologies, Knowlton claimed.

Dr. Jacques Turgeon, Chief Scientific Officer, TRHC, stated that the institute will aim to forge partnerships with academic and pharmaceutical entities, and also look forward to the opportunity to join hands with globally acclaimed organizations.

Commenting further on the launch, Knowlton affirmed that the company is thrilled to not only be a part of the innovation prevalent in Lake Nona Medical City, but also to have gained the guidance of Dr. Michaud and Dr. Turgeon, stalwarts recognized for their expertise in pharmacokinetics & drug-metabolism and research and pharmacy education respectively.

Dr. Jacques Turgeon, BPharm, PhD, for the record, has been named the CEO of the TRHC Institute, while Dr. Veronique Michaud, BPharm, PhD, will be filling in the place of the institute’s Chief Operating Officer.

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Microsoft strengthens its cloud-based services by acquiring Mover
Microsoft strengthens its cloud-based services by acquiring Mover
By Akshay Kedari

For years Microsoft Corporation has operated with a sole mission of empowering every organization and person on the planet, allowing them to achieve more. Recently, the company has shifted its focus towards Cloud and AI, as it feels that it possesses...

Netflix raises USD 2 billion in debt to fund new content creation
Netflix raises USD 2 billion in debt to fund new content creation
By Akshay Kedari

Netflix, the online-streaming video platform, is growing with an astonishing speed. The extraordinary growth of Netflix has revolutionized the media landscape. However, the company has often raised funds to invest in creating original TV shows and mo...

Norwegian Air join forces with JetBlue to expand transatlantic network
Norwegian Air join forces with JetBlue to expand transatlantic network
By Akshay Kedari

To meet increasing demand for air travel across nations and to play a lead role in the aviation industry, numerous airline companies are joining forces to roll out new plans for their passengers. A similar instance occurred recently when U.S.-based J...